The Narrow Window Between Venture Equity and Bank Debt
Venture debt is best understood as a timing instrument for an innovative startup, not as ordinary bank credit for a smaller company. This chapter focuses on the interval after outside investors have supplied evidence and equity, but before the business has the cash flow and assets that conventional senior debt normally requires. Understanding that interval helps a founder or lender identify the event meant to repay the loan—and see when preserving ownership is worth accepting a fixed obligation.
Why venture debt appears after equity
A startup does not become a good debt candidate merely because it has a promising product. Early innovation is expensive, uncertain, and often slow to monetize. The company may need to hire specialists, run trials, build infrastructure, or acquire customers before its revenue can cover its costs. An equity investor can tolerate this pattern because the investor’s return comes from the company’s eventual value. If the company fails, the equity may be worth nothing; if it succeeds, the investor shares in the upside. There is no scheduled repayment competing with research spending while the outcome is still uncertain.
A lender cannot rely on the same bargain. The lender normally receives interest and principal rather than an unlimited share of future success. They therefore need a narrower and more testable account of how the money will be repaid. That account becomes more credible after a venture-capital round for two reasons.
First, a professional investor’s decision supplies information, even if it is imperfect. The investor has examined the team, technology, market, and plan closely enough to risk equity capital. That does not prove that the company will succeed, but it can make the company’s prospects more legible than an untested pitch. Second, the investor may remain involved. A venture capitalist can monitor the company, help it recruit or commercialize, and participate in later rounds. A lender may expect that support to help the startup reach the next financing or operating milestone.
The sequence is thus not “equity for companies that deserve money, debt for companies that deserve less.” It is a division of risk across stages. Equity absorbs the widest uncertainty. Venture debt enters when some evidence exists but ordinary debt still arrives too early. Conventional senior debt becomes more plausible later, when recurring cash generation and assets make scheduled repayment less dependent on a future rescue or valuation event.
The transition is not determined by age alone. Two ten-year-old companies can present completely different credit cases. One may have stable revenue and valuable equipment; the other may still be investing in a technology whose commercial outcome is unresolved. Likewise, a young company can become a better candidate for venture debt if it has completed a meaningful development step, attracted strong investors, or raised an equity round that gives it enough cash to execute a defined plan. The relevant question is not “How old is the startup?” but “What evidence and resources exist between today’s cash burn and the intended repayment date?”
An equity round is useful evidence, but it is not a certificate of success. Venture investors can be wrong, and their decision may reflect information that a lender cannot fully inspect. The lender is not simply copying the investor’s valuation. They are asking whether the company can use a smaller, fixed claim to reach the next point at which value can be assessed. That is a different threshold from the one used by an equity investor deciding whether a potentially very large upside justifies a total loss.
The distinction becomes clearer if the company’s cash balance is viewed as a bridge between milestones. Equity may fund a broad period of exploration: several possible products, uncertain hiring needs, and a long wait for evidence. Venture debt is more defensible when the company can name what the additional cash changes. It might complete a development program, build inventory for a launch, or extend sales effort until a contract or financing event is visible. The loan does not need to make the whole business predictable. It needs to connect a defined use of cash to a future source of repayment strongly enough that the lender can accept the remaining uncertainty.
This also explains why a loan can follow equity without being redundant. Equity protects the company against the widest range of outcomes; debt can be added once the range narrows enough to support a schedule. The equity round may provide the cash cushion, investor oversight, and updated information that make the debt possible. In return, the debt may let the company delay another equity round. The two forms of capital can therefore complement each other while still having competing claims: equity benefits from upside, while debt gets paid first under the contract and may have rights over pledged assets.
The timing risk runs in both directions. If debt arrives before the company has evidence or an investor able to support it, the lender may be relying on a story that cannot be checked. If it arrives after a failed milestone has consumed the cash cushion, the loan may be used mainly to cover an existing shortfall. In that situation, the company has less time to create new value and less bargaining power if repayment becomes difficult. A recent equity infusion can make the starting position stronger, but it does not make the future event certain. The quality of the bridge depends on what happens during the borrowed period.
A useful lifecycle is:
The states are not mandatory steps for every company. They show the dependency that matters: venture debt is usually raised while the startup is still in the growth state, with a milestone or next valuation expected to move it toward repayment. If that transition fails, the same loan becomes a claim on a company that may have little cash and assets whose value is uncertain.
What “extend the runway” means
The phrase “extend the runway” sounds simple, but it describes a financial trade-off rather than a free extension of time. A startup’s runway is the period before its available cash runs out at its current spending rate. Venture debt adds cash without immediately issuing new shares. The company can use that time to complete research, launch a product, expand its market, or wait for a more favorable equity valuation. Existing owners avoid the immediate dilution that would come with selling another portion of the company.
That benefit is valuable only if time changes the company’s prospects. Suppose a development milestone is six months away and the company has a credible plan to reach it, but an equity round today would occur before the milestone and at a lower valuation. A loan may allow the company to reach the milestone and raise equity later. The lender is accepting the company’s current lack of profit because the milestone offers a plausible bridge to revenue, follow-on capital, or another source of repayment. If the milestone has no connection to customer demand or financing capacity, the same borrowing may merely postpone recognition of the problem.
A loan also changes the order in which cash is distributed. Interest and principal become claims that compete with engineering, sales, and operations. A founder who thinks only about the cash received can miss the more important question: what future cash must be reserved for the lender, and when? The company may preserve ownership percentage while reducing operating flexibility. If the next equity round is delayed, management may have to raise capital under pressure, cut productive spending, or negotiate with a lender from a weaker position.
Contract timing is meant to reduce—not erase—that pressure. The EIB’s product description illustrates the idea. It places venture debt in the late-venture or growth stage and describes a typical tenor of five to seven years, compared with one to four years for traditional venture debt and three to five years for a growth loan in the market comparison it reproduces. The EIB comparison lists €7.5 million to €50 million tickets and interest rates of 3% to 10%, excluding warrants. These are product ranges from a market overview, not terms that every borrower receives.
Longer maturity gives research-heavy projects more time to produce a return. A bullet repayment, in which much of the principal is paid at maturity, can avoid forcing a young company to divert all its early cash toward amortization. Interest-only periods can serve a similar timing purpose. Performance-linked repayment and warrants give the lender some upside for taking risk that ordinary debt would avoid. In the EIB design, warrants are generally handled for cash rather than by the EIB converting them into shares, which preserves the product’s non-dilutive character for founders in the usual equity sense. None of these features cancels the debt. They move or reshape the obligation.
Those features also decide who bears the risk of a delay. With heavy early amortization, the startup bears more of the risk that revenue arrives slowly. With a large payment at maturity, the lender bears more of the risk that the company will need to refinance at an inconvenient time—but the borrower still faces the consequences if refinancing fails. A performance-linked element can share some operating risk, while a warrant gives the lender a limited claim on upside to compensate for a loan whose downside is unusually exposed. The stated interest rate should therefore not be read as the entire price of capital when warrants or other terms are part of the contract.
Consider a company that expects a product certification to unlock sales. A loan with payments beginning before certification may force the company to cut the very work that could create repayment capacity. A loan whose major payment comes afterward preserves more operating cash, but it concentrates risk in the certification date and the financing market that follows it. The same amount of money can therefore have very different economic effects depending on when the claim becomes payable. Contract design is part of the underwriting judgment: it determines whether the company has a chance to reach the milestone without treating the lender as an unsecured partner in unlimited experimentation.
This is also why the EIB comparison should be read as an illustration of product architecture, not a menu of guaranteed offers. The report describes EIB venture debt as a late-venture or growth-stage product and contrasts it with traditional venture debt and growth loans. A longer tenor and larger ticket can fit capital-intensive research, but they can also create a larger obligation if the project fails. A lower nominal rate than some private venture-debt ranges may reduce the cash burden, but it does not by itself establish a lower total risk or cost. Security, subordination, warrants, and repayment timing all affect the bargain. The company and lender are negotiating a distribution of uncertain outcomes, not selecting a single number.
The lender’s own business model also affects the package. Banks tend to make smaller loans and may earn additional revenue from deposits and financial services, while specialized non-bank lenders can offer larger packages, accept more risk, and charge higher rates. Banks and non-banks are not simply choosing different labels for the same product. Regulation, monitoring, risk tolerance, fees, and the expected recovery path all affect what they can offer. The sources describe these differences at a market level, not as a universal rule for every provider.
The practical test is therefore a sequence of questions. What exactly will the borrowed cash accomplish? Which measurable event should occur before the loan’s major payments fall due? If that event is late, can the company continue operating and renegotiate without destroying value? If another equity round is the intended repayment source, how strong is the investor’s commitment and how much market risk sits between the company and that round? If the plan fails, what can the lender recover?
A founder may rationally prefer debt when the company’s expected increase in value from using the cash is greater than the cost of repayment and the risk of losing flexibility. A lender may rationally agree when the company’s future is uncertain but the information, investor support, contract timing, and recovery protections make the expected return acceptable. Neither side needs certainty. Both need a structure that makes the uncertainty survivable.
That last condition explains why the financing window is narrow. Too early, and there may be too little evidence about the business or too few resources behind it. Too late, and the company may have already consumed the cash that would have made the bridge useful. Venture debt works best as a financing decision tied to a credible transition, not as a way to make an impossible transition look longer. The next issue is what protects the lender when that transition does not happen: whether an intangible asset such as a patent can retain value outside the startup that created it.